Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer	Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, neoplasm, otorhinolaryngologic disease	Recruiting	Phase 2	2026-05-22		NCT05800574

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cardinal Health	1
Fox Chase Cancer Center	58

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fox Chase Cancer Center	Philadelphia	United States	259

Clinical trials